0001179110-13-011533.txt : 20130703
0001179110-13-011533.hdr.sgml : 20130703
20130703170657
ACCESSION NUMBER: 0001179110-13-011533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130701
FILED AS OF DATE: 20130703
DATE AS OF CHANGE: 20130703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP
CENTRAL INDEX KEY: 0001157601
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-274-8200
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REARDON WILLIAM S
CENTRAL INDEX KEY: 0001212646
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33277
FILM NUMBER: 13953956
MAIL ADDRESS:
STREET 1: 9 STEAMBOAT LANE
CITY: HINGHAM
STATE: MA
ZIP: 02043
4
1
edgar.xml
FORM 4 -
X0306
4
2013-07-01
0
0001157601
SYNTA PHARMACEUTICALS CORP
SNTA
0001212646
REARDON WILLIAM S
C/O SYNTA PHARMACEUTICALS CORP.
45 HARTWELL AVENUE
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2013-07-01
4
A
0
4000
0
A
23228
D
Director Stock Option (Right to Buy)
5.00
2013-07-01
4
A
0
10000
0
A
2023-07-01
Common Stock
10000
10000
D
Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2013, December 31, 2013, March 31, 2014 and June 30, 2014, provided the Reporting Person continues to serve as director of the Issuer on such date.
The option vests as to 25% of the shares on each of September 30, 2013, December 31, 2013, March 31, 2014 and June 30, 2014, provided the Reporting Person continues to serve as a director of the Issuer on such date.
/s/ Brian Keane, Attorney-in-Fact
2013-07-03